O’Melveny & Myers LLP represented Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) in its proposed public offering. The company, which develops medicines related to cancer treatment, plans to use the proceeds for research and development and general corporate purposes (more…)
A Weil team advised Morgan Stanley on a senior unsecured 364-day high grade bridge facility in connection with the $2.65 billion acquisition of Longview Timber LLC, a US-based forestry company, by Weyerhaeuser Co., a US real estate trust that is one of the largest producer of wood and cellulose fibers, from Brookfield Asset Management Inc. The bridge facility and the acquisition were announced on June 17, 2013, and the acquisition is expected to close in July (more…)
Paul Hastings, a leading global law firm, announced today that it led its client Lotte Chemical Corporation (“Lotte”), a member company of the Lotte Group and previously known as Honam Petrochemical to a complete dismissal with prejudice of a complex international Intellectual Property dispute in the United States District Court for the Middle District of Alabama Northern Division (more…)
VLP Law Group LLP is very pleased to announce that Patrick Lawler and Jacob Dy-Johnson have joined the firm’s Commercial Lending practice. Mr. Lawler joins VLP as a partner from the Corporate Finance group of the Los Angeles office of O’Melveny and Myers. Mr. Dy-Johnson joins VLP as counsel (he was previously in the Palo Alto office of Wilson Sonsini Goodrich & Rosati) (more…)
O’Melveny & Myers LLP represented Xradia Inc. in its agreement to be acquired by ZEISS. Xradia makes innovative 3-D X-ray microscopes for industrial use and academic research (more…)
Davis Polk advised J.P. Morgan Securities LLC and Barclays Capital Inc. as representatives of the initial purchasers in connection with a Rule 144A offering by NetSuite Inc. of $310 million aggregate principal amount of 0.25% convertible senior notes due 2018 (more…)
Davis Polk advised Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC as representatives of the initial purchasers in connection with a Rule 144A offering by Concur Technologies, Inc. of an aggregate principal amount of $488.75 million of its 0.5% convertible senior notes due 2018, which included $63.75 million aggregate principal amount of notes from the full exercise of the initial purchasers’ over-allotment option. In addition, Davis Polk advised Deutsche Bank AG, UBS AG, Credit Suisse International and JPMorgan Chase Bank, National Association as counterparties to convertible note hedge and warrant transactions in connection with the offering (more…)
Faegre Baker Daniels LLP is expanding its operations to Silicon Valley effective July 1, 2013. The office, which will be located at 1950 University Circle in Palo Alto, Calif., is being opened by intellectual property partners Calvin L. Litsey and David J.F. Gross, both of whom are relocating from the firm’s Minneapolis office (more…)
O’Melveny & Myers LLP represented Celsion Corporation in its registered direct offering of approximately US$9.83 million of the Company’s common stock to institutional investors led by a health care fund. The offering is subject to customary closing conditions (more…)
Goodwin Procter attorneys recently advised the underwriters, led by Citigroup, BofA Merrill Lynch, Credit Suisse and Goldman Sachs, in the PennyMac Financial Services, Inc. (PennyMac) initial public offering of more than 12 million shares of common stock at $18 per share. Shares began trading on the New York Stock Exchange under ticker “PFSI” (more…)
The Firm is representing Vingroup Joint Stock Company, Vietnam’s largest private-sector real estate operator, in connection with definitive agreements by a consortium led by an affiliate of Warburg Pincus to make a $200 million investment in Vincom Retail. The definitive agreements also include a commitment from Warburg Pincus to participate in future capital raising by Vingroup in an amount of up to US$25 million, and an opportunity for the consortium to invest an additional US$100 million in Vincom Retail to expand the platform and explore future retail property-related opportunities (more…)
Davis Polk advised Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC as joint book-running managers in connection with the $140.4 million initial public offering of 9,686,171 shares of common stock of Portola Pharmaceuticals, Inc. (including 1,263,413 shares subject to the underwriters’ over-allotment option) at $14.50 per share (more…)
